Literature DB >> 19767528

Endogenous regulation of cardiovascular function by apelin-APJ.

David N Charo1, Michael Ho, Giovanni Fajardo, Masataka Kawana, Ramendra K Kundu, Ahmad Y Sheikh, Thomas P Finsterbach, Nicholas J Leeper, Kavita V Ernst, Mary M Chen, Yen Dong Ho, Hyung J Chun, Daniel Bernstein, Euan A Ashley, Thomas Quertermous.   

Abstract

Studies have shown significant cardiovascular effects of exogenous apelin administration, including the potent activation of cardiac contraction. However, the role of the endogenous apelin-APJ pathway is less clear. To study the loss of endogenous apelin-APJ signaling, we generated mice lacking either the ligand (apelin) or the receptor (APJ). Apelin-deficient mice were viable, fertile, and showed normal development. In contrast, APJ-deficient mice were not born in the expected Mendelian ratio, and many showed cardiovascular developmental defects. Under basal conditions, both apelin and APJ null mice that survived to adulthood manifested modest decrements in contractile function. However, with exercise stress both mutant lines demonstrated consistent and striking decreases in exercise capacity. To explain these findings, we explored the role of autocrine signaling in vitro using field stimulation of isolated left ventricular cardiomyocytes lacking either apelin or APJ. Both groups manifested less sarcomeric shortening and impaired velocity of contraction and relaxation with no difference in calcium transient. Taken together, these results demonstrate that endogenous apelin-APJ signaling plays a modest role in maintaining basal cardiac function in adult mice with a more substantive role during conditions of stress. In addition, an autocrine pathway seems to exist in myocardial cells, the ablation of which reduces cellular contraction without change in calcium transient. Finally, differences in the developmental phenotype between apelin and APJ null mice suggest the possibility of undiscovered APJ ligands or ligand-independent effects of APJ.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767528      PMCID: PMC2781363          DOI: 10.1152/ajpheart.00686.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  38 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism.

Authors:  K Tatemoto; K Takayama; M X Zou; I Kumaki; W Zhang; K Kumano; M Fujimiya
Journal:  Regul Pept       Date:  2001-06-15

3.  AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration.

Authors:  S AbdAlla; H Lother; U Quitterer
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

4.  Characterization of apelin, the ligand for the APJ receptor.

Authors:  D K Lee; R Cheng; T Nguyen; T Fan; A P Kariyawasam; Y Liu; D H Osmond; S R George; B F O'Dowd
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

5.  [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.

Authors:  S D Katugampola; J J Maguire; S R Matthewson; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

6.  Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes.

Authors:  Jinhong Duan; Grant E McFadden; Anthony J Borgerding; Faye L Norby; Bonnie H Ren; Gang Ye; Paul N Epstein; Jun Ren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

7.  Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.

Authors:  Andrew D Medhurst; Carol A Jennings; Melanie J Robbins; Robert P Davis; Catherine Ellis; Kim Y Winborn; Kenneth W M Lawrie; Guillaume Hervieu; Graham Riley; Jane E Bolaky; Nicole C Herrity; Paul Murdock; John G Darker
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

8.  Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.

Authors:  Tatsuo Hashimoto; Minoru Kihara; Nozomi Imai; Shin-Ichiro Yoshida; Hiroaki Shimoyamada; Hiroaki Yasuzaki; Junji Ishida; Yoshiyuki Toya; Yoshihiro Kiuchi; Nobuhito Hirawa; Kouichi Tamura; Takuya Yazawa; Hitoshi Kitamura; Akiyoshi Fukamizu; Satoshi Umemura
Journal:  Am J Pathol       Date:  2007-09-20       Impact factor: 4.307

9.  Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.

Authors:  István Szokodi; Pasi Tavi; Gábor Földes; Sari Voutilainen-Myllylä; Mika Ilves; Heikki Tokola; Sampsa Pikkarainen; Jarkko Piuhola; Jaana Rysä; Miklós Tóth; Heikki Ruskoaho
Journal:  Circ Res       Date:  2002-09-06       Impact factor: 17.367

10.  Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.

Authors:  Xing Cheng; Xiao Shuo Cheng; Catherine C Y Pang
Journal:  Eur J Pharmacol       Date:  2003-06-06       Impact factor: 4.432

View more
  64 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

2.  Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.

Authors:  Patrick Yue; Hong Jin; Shiming Xu; Marissa Aillaud; Alicia C Deng; Junya Azuma; Ramendra K Kundu; Gerald M Reaven; Thomas Quertermous; Philip S Tsao
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

3.  ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease.

Authors:  Christopher Lathen; Yu Zhang; Jennifer Chow; Martanday Singh; Grace Lin; Vishal Nigam; Yasser A Ashraf; Jason X Yuan; Ivan M Robbins; Patricia A Thistlethwaite
Journal:  Circulation       Date:  2014-07-25       Impact factor: 29.690

4.  Apelin is a positive regulator of ACE2 in failing hearts.

Authors:  Teruki Sato; Takashi Suzuki; Hiroyuki Watanabe; Ayumi Kadowaki; Akiyoshi Fukamizu; Peter P Liu; Akinori Kimura; Hiroshi Ito; Josef M Penninger; Yumiko Imai; Keiji Kuba
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

5.  Toddler: an embryonic signal that promotes cell movement via Apelin receptors.

Authors:  Andrea Pauli; Megan L Norris; Eivind Valen; Guo-Liang Chew; James A Gagnon; Steven Zimmerman; Andrew Mitchell; Jiao Ma; Julien Dubrulle; Deepak Reyon; Shengdar Q Tsai; J Keith Joung; Alan Saghatelian; Alexander F Schier
Journal:  Science       Date:  2014-01-09       Impact factor: 47.728

6.  Apelin signaling: new G protein-coupled receptor pathway in lymphatic vascular development.

Authors:  Natalie O Karpinich; Kathleen M Caron
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02       Impact factor: 8.311

7.  Resistin-induced cardiomyocyte hypertrophy is inhibited by apelin through the inactivation of extracellular signal-regulated kinase signaling pathway in H9c2 embryonic rat cardiomyocytes.

Authors:  Jian-Wei Luo; Xian Zheng; Guan-Chang Cheng; Qun-Hui Ye; Yong-Zhi Deng; Lin Wu
Journal:  Biomed Rep       Date:  2016-09-02

8.  Increased bone mass in mice lacking the adipokine apelin.

Authors:  Lalita Wattanachanya; Wei-Dar Lu; Ramendra K Kundu; Liping Wang; Marcia J Abbott; Dylan O'Carroll; Thomas Quertermous; Robert A Nissenson
Journal:  Endocrinology       Date:  2013-04-12       Impact factor: 4.736

9.  Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects.

Authors:  Cheol Hwangbo; Jingxia Wu; Irinna Papangeli; Takaomi Adachi; Bikram Sharma; Saejeong Park; Lina Zhao; Hyekyung Ju; Gwang-Woong Go; Guoliang Cui; Mohammed Inayathullah; Judith K Job; Jayakumar Rajadas; Stephanie L Kwei; Ming O Li; Alan R Morrison; Thomas Quertermous; Arya Mani; Kristy Red-Horse; Hyung J Chun
Journal:  Sci Transl Med       Date:  2017-09-13       Impact factor: 17.956

10.  Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan.

Authors:  Rahul Rai; Asish K Ghosh; Mesut Eren; Alexander R Mackie; Daniel C Levine; So-Youn Kim; Jonathan Cedernaes; Veronica Ramirez; Daniele Procissi; Layton H Smith; Teresa K Woodruff; Joseph Bass; Douglas E Vaughan
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.